Health Care

Health Care - Life Sciences Technology & Commercialization

Clinical Research and Clinical Trials

We understand the unique and complex challenges and protocols of clinical research and clinical trials. Stites & Harbison health care lawyers represent academic medical centers, teaching hospitals, universities and other institutions, as well as principle investigators. We counsel clients in the numerous standard agreements associated with clinical research (master service agreements, confidential disclosure agreements, material transfer agreements, federal and private contracts, grants, clinical and research service agreements, etc.), scientific integrity, scientific misconduct, privacy, human subject protection, and FDA reporting. Our clients also include biotechnology, life sciences, pharmaceutical and medical device companies.

We serve our clients in areas including:

Intellectual Property Protection Counseling

  • Patentability, freedom to operate, patent infringement, and patent validity analyses.
  • Preparation and prosecution of domestic and international patent applications.
  • Due diligence analysis including review and assessment of existing intellectual property portfolios.
  • Trademark availability analyses.
  • Preparation and prosecution of domestic and international trademark applications.
  • Domain name disputes resolution; domain name assignments and sales agreements.
  • Privacy policies and terms-of-use for commercial web sites.
  • Traditional and web site advertising review.

Enforcement of Intellectual Property Rights and Litigation:

  • Appeals to U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences
  • Defense and prosecution of patent infringement lawsuits and declaratory judgment actions in federal court
  • Defense and prosecution of trademark and copyright infringement lawsuits in federal court and before administrative bodies, including the USPTO Trademark Trial and Appeal Board and U.S. Copyright Office

Intellectual Property Licensing and Technology Transfer

  • Non-disclosure agreements and internal confidentiality policies
  • Review of co-branding, Internet, and traditional advertising agreements

Risk Management for Pharmaceutical, Biomedical, and Biotechnology product launch

Main Contact
See more related to Health Care - Life Sciences Technology & Commercialization
Press Releases

Stites & Harbison ranks 7th in ABA Health Law Section's Regional Top 10 List for 2019

LOUISVILLE, Ky.—The American Bar Association (ABA) Health Law Section has ranked Stites & Harbison, PLLC in 7th place in its Seventh Annual Regional Law Firm Recognition List for the South region for 2019. This year marks Stites & Harbison’s sixth consecutive time being named to the Top 10 list.

by Stites & Harbison, PLLC November 05, 2019
Press Releases

Managing IP selects Mandy Wilson Decker to 2019 "Top 250 Women in IP" List

LOUISVILLE, Ky.—Managing Intellectual Property magazine recently selected Stites & Harbison, PLLC attorney Mandy Wilson Decker to the 2019 edition of Managing Intellectual Property’s “Top 250 Women in IP.”

by Stites & Harbison, PLLC May 22, 2019
Press Releases

Terry Wright Elected to Fund for the Arts Board

LOUISVILLE, Ky.—Fund for the Arts has elected Stites & Harbison, PLLC attorney Terry Wright to its Board of Directors. He will serve a three-year term.

by Stites & Harbison, PLLC May 15, 2019
Events

Intellectual Property Seminars

Date: 5/16/19 - 5/17/19

Marshall University, Huntington, W.Va.

Attorney Terry Wright will present three free intellectual property seminars focusing on 3-D designs and manufactured goods, pharmaceuticals and medical devices presented by the Marshall University Technology Transfer Office in Hunington, W.Va.

Terry L. Wright April 19, 2019
Client Alerts

Taking Stock of Your 2019 Cybersecurity Resolutions

Did you decide that 2019 will be the year you tackle those cybersecurity threats to your organization that keep you up at night? It’s February, and a good time to take stock of whether your organization is following through on its cybersecurity goals. Some estimate that 80% of resolutions fail by the second week of February.

by Jennifer Henry Jackson, and Sarah Cronan Spurlock February 08, 2019